Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa for Residual Amblyopia
NCT01190813Phase 3Completed
- Sponsor
- Jaeb Center for Health Research
- Start
- Sep 2010
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levodopa in amblyopia, sponsored by Jaeb Center for Health Research. Started Sep 2010; status: completed.
02
Drugs
levodopa
03
Conditions
amblyopia
Beyond the preview
Go deeper on NCT01190813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01190813.